Clinical Trial Update: Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing long-term immune memory after 2 vs 3 doses of Quad-HPV vaccine for human papillomavirus; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Disease
• Human Papillomavirus Infection

Drugs mentioned

• Quad-HPV vaccine

Snippet

Sponsor: University of British Columbia | Conditions: Human Papillomavirus | Phase 4 | Status: COMPLETED | Results posted: 2021-06-25